Skip to main content
. 2015 Sep 1;6(5):e00731-15. doi: 10.1128/mBio.00731-15

FIG 4 .

FIG 4 

DNA damage repair system mutants have reduced survival after ofloxacin treatment in stationary phase. Ofloxacin persisters decreased approximately 104-fold in ΔrecA mutants, 103-fold in ΔrecB mutants, and 50-fold in ΔruvA and ΔrecN mutants. ΔrecF, ΔtisAB, and ΔdksA resulted in persister levels comparable to those of the WT. Data are average values ± standard errors from at least three biological replicates.